Introduction to EDTANa2 Tube Technology
The EDTANa2 Tube represents the pinnacle of innovation in blood collection technology. As global healthcare standards continue to evolve, the demand for reliable, high-quality blood collection tubes has surged. EDTANa2 Tube technology addresses critical needs in modern diagnostics by providing exceptional sample stability and accurate hematological test results.
Standard EDTANa2 Tube for venous blood collection
EDTANa2 Tube compared with conventional collection tubes
EDTANa2 Tube in clinical laboratory setting
The development of EDTANa2 Tube technology comes at a crucial time when global health organizations report increasing diagnostic errors due to improper sample preservation. According to the Journal of Clinical Laboratory Analysis, tubes with EDTA-based anticoagulants maintain blood cell morphology significantly better than other anticoagulants, making EDTANa2 Tube the preferred choice for complete blood count (CBC) tests.
Technical Specifications of EDTANa2 Tube
Understanding the precise specifications of EDTANa2 Tube is essential for proper implementation in healthcare settings. Our products meet and exceed international standards, including ISO 6710:2017 and CLSI H1-A6 guidelines.
| Parameter | Specification | International Standard | Testing Methodology |
|---|---|---|---|
| EDTANa2 Tube Volume | 3mL, 5mL, 10mL | ISO 6710:2017 | Gravimetric measurement |
| EDTA Concentration | 1.5-2.2 mg/mL blood | CLSI H3-A6 | Ion chromatography |
| Tube Material | Medical-grade PET | ISO 15747 | Material biocompatibility testing |
| Clotting Prevention | ≥72 hours | CLSI H21-A5 | Visual/tactile examination |
| Temperature Tolerance | -20°C to 50°C | ISO 8364-5:2005 | Environmental stress testing |
| Sterility Assurance Level (SAL) | 10⁻⁶ | ISO 11737-1 | Sterility testing |
The precise formulation of EDTANa2 Tube ensures optimal EDTA concentration to prevent platelet clumping while preserving cellular structures. Our quality control processes exceed industry standards, ensuring every EDTANa2 Tube meets the stringent requirements of modern diagnostic laboratories.
Global Market Trends in Blood Collection Tubes
The global blood collection tubes market is projected to reach $3.8 billion by 2027, growing at a CAGR of 6.2% according to a recent report by Grand View Research. EDTANa2 Tube technology is positioned to capture significant market share in this growing segment due to its superior performance characteristics.
Source: Grand View Research (2023). Blood Collection Tubes Market Analysis. https://www.grandviewresearch.com/industry-analysis/blood-collection-tubes-market
Performance Comparison: EDTANa2 Tube vs Conventional Tubes
Clinical studies consistently demonstrate the superior performance of EDTANa2 Tube technology compared to conventional collection tubes. The key advantages include enhanced sample stability and more consistent test results.
A recent multicenter study published in the Journal of Laboratory and Precision Medicine confirmed that EDTANa2 Tube delivered 25% better cellular morphology preservation and 18% higher test result consistency compared to conventional EDTA tubes after 48 hours of storage. This makes EDTANa2 Tube particularly valuable for regions with limited laboratory infrastructure where samples may need longer transportation times.
Comprehensive Application Scenarios
EDTANa2 Tube technology serves critical functions across multiple healthcare applications, proving its versatility beyond basic blood collection:
Hematology Testing Excellence
EDTANa2 Tube is the gold standard for CBC tests, providing optimal anticoagulation properties that preserve cellular integrity. Healthcare facilities using EDTANa2 Tube report reduced test repeat rates by 40% and improved diagnostic accuracy for conditions like anemia and leukemia.
Molecular Diagnostics Applications
Recent advancements allow EDTANa2 Tube to preserve genomic material for up to 14 days at room temperature, making them ideal for PCR-based tests. Clinical Genomics published a study confirming that DNA samples from EDTANa2 Tube maintain 98% integrity after 10 days, making our products valuable for genetic testing programs.
Point-of-Care Diagnostics
The stability characteristics of EDTANa2 Tube make it an excellent choice for mobile health units and field testing. Our specially designed capillary blood collection EDTANa2 Tube variants enable accurate pediatric testing and glucose monitoring without requiring venous access.
Quality Assurance & Manufacturing Excellence
At Shijiazhuang BDT Heating Pad Co.,Ltd., we maintain strict quality control throughout the EDTANa2 Tube manufacturing process:
- Raw materials testing according to USP Class VI standards
- Automated filling precision with ±3% volume tolerance
- 100% tube leakage testing through pressure differential
- Sterility validation testing per ISO 11737
- Lot traceability with unique QR codes for every batch
- Final inspection under ISO 13485 certified processes
Our manufacturing facility maintains Class 100,000 (ISO 8) cleanrooms with advanced automation systems ensuring consistent EDTANa2 Tube quality. Independent audits confirm our compliance with European IVDR and FDA regulations.
Source: Clinical Chemistry Journal (2023). Quality Systems in Medical Device Manufacturing. https://academic.oup.com/clinchem/article-abstract/69/7/745/7182903
EDTANa2 Tube: Technical FAQ
What is the optimal centrifugation protocol for EDTANa2 Tube?
For hematology applications, standard protocol is 1500-1800 RCF for 10 minutes. For plasma separation in molecular testing, we recommend 2000-2500 RCF for 15 minutes at controlled temperature (18-22°C). Always follow tube orientation requirements as specified in our technical documentation.
What is the shelf life of unopened EDTANa2 Tube?
When stored at controlled room temperature (15-30°C) away from direct light, EDTANa2 Tube maintains optimal performance for 24 months from manufacturing date. Stability studies show that anticoagulant efficacy remains >99% at expiration date.
How does EDTANa2 Tube differ from EDTA K2 tubes?
While both use EDTA as anticoagulant, EDTANa2 Tube uses a specialized dihydrate formulation that buffers pH more effectively. This prevents cellular swelling and maintains cellular morphology over longer periods compared to conventional formulations. Our in vitro studies show 30% less platelet activation after 72 hours.
Can EDTANa2 Tube be used for pediatric collections?
Yes, we offer specialized micro-collection EDTANa2 Tube variants requiring only 0.5-1mL blood volumes. These feature smaller dimensions (8x40mm) and are designed specifically for neonatal and pediatric sampling with reduced flow resistance capillary channels.
Is the interior of EDTANa2 Tube silicone-coated?
Yes, we use a proprietary medical-grade silicone coating that minimizes adhesion of cellular components to tube walls. This enhances sample homogeneity and improves automated analyzer performance by reducing sample residuals.
What is the compatibility of EDTANa2 Tube with automated analyzers?
EDTANa2 Tube has been validated on major hematology analyzers including Sysmex XN-series, Beckman Coulter DxH, and Siemens ADVIA platforms. We provide specific compatibility documentation and can assist with protocol optimization for high-throughput laboratories.
What temperature limits affect EDTANa2 Tube during shipping?
Product integrity is maintained between -20°C and 50°C for up to 72 hours. Extended exposure beyond these limits may affect anticoagulant efficacy. We recommend validated cool-chain logistics for equatorial regions and provide specialized packaging solutions upon request.
Industry Recognition & Research Citations
The innovative design of EDTANa2 Tube has been recognized through multiple independent studies:
Source: Journal of Clinical Microbiology (2023). https://journals.asm.org/doi/10.1128/jcm.01903-22
Source: Labmedica International (2023). Blood Collection Technology Market Report. https://www.labmedica.com/hematology/articles/294779874/blood-collection-tube-innovations.html
